A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(127 sites)
United States
Arizona Arthritis and Rheumatology Research PLLC, Mesa, Arizona UCLA, Los Angeles, California Hoag Hospital, Newport Beach, California Clinical Res Of W Florida, Clearwater, Florida GNP Research, Cooper City, Florida IRIS Research and Development, Plantation, Florida Sarasota Arthritis Res Ctr, Sarasota, Florida University of Chicago Hospitals, Chicago, Illinois UMC New Orleans, New Orleans, Louisiana Uni Of Michigan Health System, Ann Arbor, Michigan Wayne State University, Detroit, Michigan Clinical Research Inst of MI, Saint Clair Shores, Michigan Hospital for Special Surgery, New York, New York West Tennessee Research Institute, Jackson, Tennessee Arthritis and Rheumatology Ins, Allen, Texas Novel Research LLC, Bellaire, Texas Prolato Clinical Research Center, Houston, Texas Argentina
Novartis Investigative Site, CABA, Buenos Aires Novartis Investigative Site, CABA, Buenos Aires Novartis Investigative Site, Caba Novartis Investigative Site, Caba Novartis Investigative Site, San Miguel de Tucumán Austria
Novartis Investigative Site, Graz Belgium
Novartis Investigative Site, Leuven Brazil
Novartis Investigative Site, Salvador, Estado de Bahia Novartis Investigative Site, Curitiba, Paraná Novartis Investigative Site, Porto Alegre, Rio Grande do Sul Novartis Investigative Site, Sao Jose Rio Preto, São Paulo Novartis Investigative Site, São Paulo, São Paulo Novartis Investigative Site, São Paulo, São Paulo China
Novartis Investigative Site, Nanning, Guangxi Novartis Investigative Site, Zhengzhou, Henan Novartis Investigative Site, Changchun, Jilin Novartis Investigative Site, Chengdu, Sichuan Novartis Investigative Site, Ningbo, Zhejiang Novartis Investigative Site, Beijing Novartis Investigative Site, Beijing Novartis Investigative Site, Tianjin Colombia
Novartis Investigative Site, Medellín, Antioquia Novartis Investigative Site, Bogota, Cundinamarca Novartis Investigative Site, Bogota, Cundinamarca Novartis Investigative Site, Cali, Valle del Cauca Department Novartis Investigative Site, Bogotá Novartis Investigative Site, Medellín France
Novartis Investigative Site, Dijon Novartis Investigative Site, Le Mans Novartis Investigative Site, Lille Novartis Investigative Site, Montpellier Novartis Investigative Site, Paris Novartis Investigative Site, Rennes Novartis Investigative Site, Strasbourg Novartis Investigative Site, Toulouse Germany
Novartis Investigative Site, Würzburg, Bavaria Novartis Investigative Site, Jena, Thuringia Novartis Investigative Site, Berlin Greece
Novartis Investigative Site, Alexandroupoli Novartis Investigative Site, Athens Novartis Investigative Site, Athens Hungary
Novartis Investigative Site, Pécs, Baranya Novartis Investigative Site, Debrecen, Hajdu Bihar Megye Novartis Investigative Site, Budapest India
Novartis Investigative Site, Kochi, Kerala Novartis Investigative Site, Mumbai, Maharashtra Novartis Investigative Site, Mumbai, Maharashtra Novartis Investigative Site, New Delhi, National Capital Territory of Delhi Novartis Investigative Site, Jaipur, Rajasthan Novartis Investigative Site, New Delhi Italy
Novartis Investigative Site, Ancona, AN Novartis Investigative Site, Milan, MI Novartis Investigative Site, Rozzano, MI Novartis Investigative Site, Modena, MO Novartis Investigative Site, Palermo, PA Novartis Investigative Site, Pavia, PV Novartis Investigative Site, Roma, RM Novartis Investigative Site, Verona, VR Japan
Novartis Investigative Site, Nagoya, Aichi-ken Novartis Investigative Site, Kitakyushu, Fukuoka Novartis Investigative Site, Maebashi, Gunma Novartis Investigative Site, Sapporo, Hokkaido Novartis Investigative Site, Sapporo, Hokkaido Novartis Investigative Site, Kanazawa, Ishikawa-ken Novartis Investigative Site, Yokohama, Kanagawa-ku Novartis Investigative Site, Suita, Osaka Novartis Investigative Site, Iruma-gun, Saitama Novartis Investigative Site, Bunkyo-ku, Tokyo Novartis Investigative Site, Chuo Ku, Tokyo Novartis Investigative Site, Shinjuku Ku, Tokyo Novartis Investigative Site, Shinjuku-ku, Tokyo Malaysia
Novartis Investigative Site, Cheras, Kuala Lumpur Novartis Investigative Site, Kuala Lumpur Mexico
Novartis Investigative Site, Guadalajara, Jalisco Novartis Investigative Site, Mexico City, Mexico City Novartis Investigative Site, Mexico City, Mexico City Novartis Investigative Site, Monterrey, Nuevo León Novartis Investigative Site, Chihuahua City Poland
Novartis Investigative Site, Bydgoszcz Novartis Investigative Site, Warsaw Portugal
Novartis Investigative Site, Coimbra Novartis Investigative Site, Lisbon Novartis Investigative Site, Vila Nova de Gaia South Korea
Novartis Investigative Site, Seoul, Korea Novartis Investigative Site, Busan Novartis Investigative Site, Seoul Novartis Investigative Site, Seoul Spain
Novartis Investigative Site, Málaga, Andalusia Novartis Investigative Site, Valencia, Valencia Novartis Investigative Site, Barcelona Novartis Investigative Site, Madrid Novartis Investigative Site, Salamanca Taiwan
Novartis Investigative Site, Changhua Novartis Investigative Site, Kaohsiung City Novartis Investigative Site, Taichung Novartis Investigative Site, Taoyuan District Thailand
Novartis Investigative Site, Khon Kaen, THA Novartis Investigative Site, Bangkok Turkey (Türkiye)
Novartis Investigative Site, Istanbul, Fatih Novartis Investigative Site, Ankara, Sihhiye-Altindag Novartis Investigative Site, Ankara, Yenimahalle United Kingdom
Novartis Investigative Site, Basingstoke, Hampshire Novartis Investigative Site, Bristol Novartis Investigative Site, London Vietnam
Novartis Investigative Site, Ho Chi Minh City, VNM Novartis Investigative Site, Ho Chi Minh City Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Hiroshima Novartis Investigative Site, Kyoto Novartis Investigative Site, Toyama